MTSR

$0.00

(

0.00%

)
Quote details

stock

Metsera, Inc. Common Stock

NASDAQ | MTSR

70.50

USD

$0.00

(

0.00%

)

At Close (As of Nov 13, 2025)

$7.43B

Market Cap

-

P/E Ratio

-2.99

EPS

$83.86

52 Week High

$12.30

52 Week Low

HEALTHCARE

Sector

MTSR Chart

Recent Chart
Price Action

MTSR Technicals

Tags:

MTSR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$14K
Total Revenue $0
Cost Of Revenue $14K
Costof Goods And Services Sold $14K
Operating Income -$225M
Selling General And Administrative $27M
Research And Development $108M
Operating Expenses $225M
Investment Income Net -
Net Interest Income $6M
Interest Income $6.2M
Interest Expense $223K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14K
Income Before Tax -$218M
Income Tax Expense -$9.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$209M
Comprehensive Income Net Of Tax -
Ebit -$218M
Ebitda -$218M
Net Income -$209M

Revenue & Profitability

Earnings Performance

MTSR Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$14K
Total Revenue $0
Cost Of Revenue $14K
Costof Goods And Services Sold $14K
Operating Income -$225M
Selling General And Administrative $27M
Research And Development $108M
Operating Expenses $225M
Investment Income Net -
Net Interest Income $6M
Interest Income $6.2M
Interest Expense $223K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $14K
Income Before Tax -$218M
Income Tax Expense -$9.3M
Interest And Debt Expense -
Net Income From Continuing Operations -$209M
Comprehensive Income Net Of Tax -
Ebit -$218M
Ebitda -$218M
Net Income -$209M

MTSR News

MTSR Profile

Metsera, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Metsera, Inc. is a clinical-stage biotechnology firm based in New York, focused on developing cutting-edge injectable and oral hormone analog peptides designed for obesity and related metabolic disorders. Leveraging advanced peptide technology, the company aspires to transform obesity treatment through its innovative therapeutic solutions. With a strong pipeline and a commitment to scientific advancement, Metsera presents significant growth potential within the health and wellness sector, making it an appealing investment opportunity for institutional investors interested in the evolving biotech industry.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
WBD
-0.13%
$29.49
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
EXK
+4.20%
$9.41
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
WBD
-0.13%
$29.49
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
EXK
+4.20%
$9.41

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.